Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Diabetes mellitus4971 records.
Article ID | PMID | Source | Title | Publish Year | |
---|---|---|---|---|---|
A06887 | 32709942 | Sci Rep | Prevalence and staging of non-alcoholic fatty liver disease among patients with heart failure with preserved ejection fraction. | 2020 | Details |
A06891 | 32707957 | Nutrients | Eating Fast Is Associated with Nonalcoholic Fatty Liver Disease in Men But Not in Women with Type 2 Diabetes: A Cross-Sectional Study. | 2020 | Details |
A06895 | 32706931 | Liver Int | Factors independently associated with cardiorespiratory fitness in patients with non-alcoholic fatty liver disease. | 2020 | Details |
A06897 | 32706078 | Eur Rev Med Pharmacol Sci | Mediterranean diet and the prevention of non-alcoholic fatty liver disease: results from a case-control study. | 2020 | Details |
A06915 | 32698692 | United European Gastroenterol J | Non-alcoholic fatty liver disease increases the risk of incident chronic kidney disease. | 2020 | Details |
A06925 | 32696080 | Clin Res Cardiol | NAFLD and cardiovascular diseases: a clinical review. | 2020 | Details |
A06948 | 32690182 | Clin Nutr ESPEN | Non-alcoholic fatty liver disease (NAFLD) among underweight adults. | 2020 | Details |
A06950 | 32690054 | BMC Public Health | Insights from qualitative research on NAFLD awareness with a cohort of T2DM patients: time to go public with insulin resistance? | 2020 | Details |
A06965 | 32684739 | World J Gastroenterol | Medications in type-2 diabetics and their association with liver fibrosis. | 2020 | Details |
A06966 | 32684526 | Endocr J | Association between hemoglobin levels and non-alcoholic fatty liver disease in patients with young-onset type 2 diabetes mellitus. | 2020 | Details |
A06974 | 32681291 | Obes Surg | 1-Year Follow-up of Single Anastomosis Sleeve Ileal (SASI) Bypass in Morbid Obese Patients: Efficacy and Concerns. | 2020 | Details |
A06977 | 32679195 | Arch Biochem Biophys | (-)-Epicatechin and the comorbidities of obesity. | 2020 | Details |
A06979 | 32677717 | Diabetes Metab Res Rev | NAFLD in type 2 diabetes mellitus: Still many challenging questions. | 2020 | Details |
A06986 | 32671767 | Adv Exp Med Biol | Autophagy and Obesity and Diabetes. | 2020 | Details |
A06990 | 32670822 | J Tradit Complement Med | The synergistic effect of Citrus bergamia and Cynara cardunculus extracts on vascular inflammation and oxidative stress in non-alcoholic fatty liver disease. | 2020 | Details |
A06993 | 32668632 | Int J Mol Sci | Common Drug Pipelines for the Treatment of Diabetic Nephropathy and Hepatopathy: Can We Kill Two Birds with One Stone? | 2020 | Details |
A06994 | 32668273 | Magn Reson Imaging | Noninvasive assessment of abdominal adipose tissues and quantification of hepatic and pancreatic fat fractions in type 2 diabetes mellitus. | 2020 | Details |
A06997 | 32666779 | Pol Arch Intern Med | Nonalcoholic fatty liver disease and the risk of metabolic comorbidities: how to manage in clinical practice. | 2020 | Details |
A06998 | 32666675 | Liver Int | Hepatitis B virus-related hepatocellular carcinoma in the era of antiviral therapy: The emerging role of non-viral risk factors. | 2020 | Details |
A06999 | 32666604 | FASEB J | Liver CPT1A gene therapy reduces diet-induced hepatic steatosis in mice and highlights potential lipid biomarkers for human NAFLD. | 2020 | Details |
A07007 | 32660189 | Zhonghua Gan Zang Bing Za Zhi | [Pancreatoduodenectomy and non-alcoholic fatty liver disease]. | 2020 | Details |
A07013 | 32657776 | J Clin Invest | AGER1 downregulation associates with fibrosis in nonalcoholic steatohepatitis and type 2 diabetes. | 2020 | Details |
A07018 | 32655232 | J Clin Exp Hepatol | Diabetes and Hepatocellular Carcinoma: Incidence Trends and Impact of Liver Disease Etiology. | 2019 | Details |
A07020 | 32654989 | Pancreatology | Three-dimensional remnant pancreatic volume ratio indicates postoperative pancreatic exocrine insufficiency in pancreatic cancer patients after distal pancreatectomy. | 2020 | Details |
A07026 | 32654086 | Dig Dis Sci | Nonalcoholic Fatty Liver Disease Risk Factors Affect Liver-Related Outcomes After Direct-Acting Antiviral Treatment for Hepatitis C. | 2020 | Details |
A07027 | 32652824 | Liver Int | NAFLD is related to Post-prandial Triglyceride-enrichment of HDL Particles in Association with Endothelial and HDL Dysfunction. | 2020 | Details |
A07034 | 32650222 | Nutr Res | Distinct utilization of biotin in and between adipose and brain during aging is associated with a lipogenic shift in Wistar rat brain. | 2020 | Details |
A07049 | 32642003 | Theranostics | Current understanding of the role of Adipose-derived Extracellular Vesicles in Metabolic Homeostasis and Diseases: Communication from the distance between cells/tissues. | 2020 | Details |
A07053 | 32640105 | J Intern Med | A systems biology approach to understand gut microbiota and host metabolism in morbid obesity: design of the BARIA Longitudinal Cohort Study. | 2020 | Details |
A07054 | 32639223 | Int J Vitam Nutr Res | Vitamin D levels are not associated with non-alcoholic fatty liver disease severity in a Brazilian population. | 2020 | Details |
A07055 | 32638913 | Rev Col Bras Cir | Comparison of the severity of non-alcoholic fatty liver disease in diabetic and non-diabetic obese patients. | 2020 | Details |
A07058 | 32638496 | Liver Int | Non-invasive risk scores do not reliably identify future cirrhosis or hepatocellular carcinoma in Type 2 diabetes: The Edinburgh type 2 diabetes study. | 2020 | Details |
A07082 | 32629394 | EBioMedicine | MBOAT7 down-regulation by genetic and environmental factors predisposes to MAFLD. | 2020 | Details |
A07084 | 32629123 | Clin Gastroenterol Hepatol | Lean Americans With Nonalcoholic Fatty Liver Disease Have Lower Rates of Cirrhosis and Comorbid Diseases. | 2020 | Details |
A07085 | 32628898 | United European Gastroenterol J | Metabolic endoscopy: Today's science-tomorrow's treatment. | 2020 | Details |
A07092 | 32626782 | J Diabetes Res | Thrombospondin-1: A Key Protein That Induces Fibrosis in Diabetic Complications. | 2020 | Details |
A07111 | 32619031 | Diabet Med | Mechanisms, screening modalities and treatment options for individuals with non-alcoholic fatty liver disease and type 2 diabetes. | 2020 | Details |
A07117 | 32616276 | Can J Diabetes | Liver Stiffness Is Associated With Progression of Albuminuria in Adults With Type 2 Diabetes: Nonalcoholic Fatty Disease Cohort Study. | 2020 | Details |
A07128 | 32610115 | J Hepatol | Suboptimal reliability of liver biopsy evaluation has implications for randomized clinical trials. | 2020 | Details |
A07149 | 32599713 | Int J Mol Sci | Fructose and Uric Acid: Major Mediators of Cardiovascular Disease Risk Starting at Pediatric Age. | 2020 | Details |
A07153 | 32598639 | Ter Arkh | [Diabetes mellitus and chronic liver diseases. Part 1: general mechanisms of etiology and pathogenesis]. | 2019 | Details |
A07155 | 32598584 | Ter Arkh | [Peculiarities of heart risk in patients with non - alcoholic fatial liver disease]. | 2019 | Details |
A07156 | 32598051 | Aliment Pharmacol Ther | Clinical assessment for high-risk patients with non-alcoholic fatty liver disease in primary care and diabetology practices. | 2020 | Details |
A07160 | 32595949 | F1000Res | Dyslipidemia as a risk factor for liver fibrosis progression in a multicentric population with non-alcoholic steatohepatitis. | 2020 | Details |
A07165 | 32595023 | Obes Res Clin Pract | Pro-inflammatory HDL in women with obesity and nonalcoholic steatohepatitis. | 2020 | Details |
A07167 | 32594797 | Hypertension | Nonalcoholic Fatty Liver Disease and Advanced Fibrosis in US Adults Across Blood Pressure Categories. | 2020 | Details |
A07180 | 32591906 | Pflugers Arch | Glucose transporters in adipose tissue, liver, and skeletal muscle in metabolic health and disease. | 2020 | Details |
A07189 | 32588824 | Biomed Khim | [The inhibitors of the apical sodium-dependent bile acid transporter (ASBT) as promising drugs]. | 2020 | Details |
A07195 | 32586479 | Clin Geriatr Med | Nonalcoholic Fatty Liver Disease and Implications for Older Adults with Diabetes. | 2020 | Details |
A07207 | 32583444 | J Gastroenterol Hepatol | Modest alcohol intake not associated with significant hepatic steatosis or more severe liver disease among patients with diabetes mellitus. | 2020 | Details |
A07208 | 32582754 | Front Nutr | PTEN: A Thrifty Gene That Causes Disease in Times of Plenty? | 2020 | Details |
A07209 | 32581841 | Front Physiol | Dysregulated Neurovascular Control Underlies Declining Microvascular Functionality in People With Non-alcoholic Fatty Liver Disease (NAFLD) at Risk of Liver Fibrosis. | 2020 | Details |
A07219 | 32577775 | Inflamm Res | Pathobiological and molecular connections involved in the high fructose and high fat diet induced diabetes associated nonalcoholic fatty liver disease. | 2020 | Details |
A07231 | 32573497 | JCI Insight | Leptin decreases de novo lipogenesis in patients with lipodystrophy. | 2020 | Details |
A07240 | 32571100 | J Endourol | Nonalcoholic Fatty Liver Disease Is an Independent Risk Factor for Nephrolithiasis in Women: Findings from NHANES III. | 2020 | Details |
A07241 | 32571083 | Ann Pharmacother | A Systematic Review of Newer Antidiabetic Agents in the Treatment of Nonalcoholic Fatty Liver Disease. | 2020 | Details |
A07243 | 32570776 | Int J Mol Sci | Epidemiology: Pathogenesis, and Diagnostic Strategy of Diabetic Liver Disease in Japan. | 2020 | Details |
A07244 | 32569680 | Metabolism | Metabolic liver disease in diabetes - From mechanisms to clinical trials. | 2020 | Details |
A07259 | 32563249 | Lipids Health Dis | Association between fasting plasma glucose and nonalcoholic fatty liver disease in a nonobese Chinese population with normal blood lipid levels: a prospective cohort study. | 2020 | Details |
A07281 | 32556752 | Surg Endosc | Long-term effects of one-anastomosis gastric bypass on liver histopathology in NAFLD cases: a prospective study. | 2020 | Details |
A07286 | 32554851 | Aging (Albany NY) | CTRP13 attenuates the expression of LN and CAV-1 Induced by high glucose via CaMKKβ/AMPK pathway in rLSECs. | 2020 | Details |
A07295 | 32553151 | Lancet Gastroenterol Hepatol | Novel antisense inhibition of diacylglycerol O-acyltransferase 2 for treatment of non-alcoholic fatty liver disease: a multicentre, double-blind, randomised, placebo-controlled phase 2 trial. | 2020 | Details |
A07299 | 32550751 | World J Gastroenterol | Post-transplant diabetes mellitus and preexisting liver disease - a bidirectional relationship affecting treatment and management. | 2020 | Details |
A07307 | 32545650 | Nutrients | Serum Mac-2 Binding Protein Levels Associate with Metabolic Parameters and Predict Liver Fibrosis Progression in Subjects with Fatty Liver Disease: A 7-Year Longitudinal Study. | 2020 | Details |
A07318 | 32540813 | Ann Biol Clin (Paris) | [Mutltifaceted biological roles of adiponectin]. | 2020 | Details |
A07330 | 32534588 | Cardiovasc Diabetol | Non-alcoholic steatohepatitis and progression of carotid atherosclerosis in patients with type 2 diabetes: a Korean cohort study. | 2020 | Details |
A07331 | 32534575 | Cardiovasc Diabetol | Cardiovascular morbidity, diabetes and cancer risk among children and adolescents with severe obesity. | 2020 | Details |
A07349 | 32529412 | Diabetologia | Exercise and metabolic health: beyond skeletal muscle. | 2020 | Details |
A07351 | 32528557 | Diabetol Metab Syndr | Association of [1H]-MRS quantified liver fat content with glucose metabolism status. | 2020 | Details |
A07374 | 32522731 | BMJ Open Diabetes Res Care | Regional difference in the susceptibility of non-alcoholic fatty liver disease in China. | 2020 | Details |
A07379 | 32520458 | Rev Med Suisse | [NASH: a less known but severe complication of diabetes]. | 2020 | Details |
A07382 | 32519009 | Curr Diab Rep | Purine Metabolite Signatures and Type 2 Diabetes: Innocent Bystanders or Actionable Items? | 2020 | Details |
A07393 | 32515888 | J Occup Health | Effects of obesity, metabolic syndrome, and non-alcoholic or alcoholic elevated liver enzymes on incidence of diabetes following lifestyle intervention: A subanalysis of the J-DOIT1. | 2020 | Details |
A07394 | 32515880 | Liver Int | Mechanisms for increased risk of diabetes in chronic liver diseases. | 2020 | Details |
A07405 | 32514025 | Nutr Diabetes | Association between famine exposure in early life with insulin resistance and beta cell dysfunction in adulthood. | 2020 | Details |
A07406 | 32513303 | Stem Cell Res Ther | Mesenchymal stem cell-derived exosomes exert ameliorative effects in type 2 diabetes by improving hepatic glucose and lipid metabolism via enhancing autophagy. | 2020 | Details |
A07426 | 32504921 | Biomed Pharmacother | The influence of probiotics on bile acids in diseases and aging. | 2020 | Details |
A07433 | 32499209 | J Formos Med Assoc | Pathologic findings of patients with nonalcoholic fatty liver disease and the impact of concurrent hepatitis B virus infection in Taiwan. | 2020 | Details |
A07444 | 32494263 | Pak J Med Sci | Fatty liver in Pakistani cohort with rheumatoid arthritis. | 2022 | Details |
A07450 | 32490903 | Arq Gastroenterol | PANCREATIC STEATOSIS: A NEW DIAGNOSIS AND THERAPEUTIC CHALLENGE IN GASTROENTEROLOGY. | 2020 | Details |
A07462 | 32485838 | Int J Mol Sci | The Role of Insulin Resistance and Diabetes in Nonalcoholic Fatty Liver Disease. | 2020 | Details |
A07479 | 32478487 | Liver Int | Comparison of MAFLD and NAFLD diagnostic criteria in real world. | 2020 | Details |
A07480 | 32478287 | Nat Metab | Resolution of NASH and hepatic fibrosis by the GLP-1R/GcgR dual-agonist Cotadutide via modulating mitochondrial function and lipogenesis. | 2020 | Details |
A07481 | 32477116 | Front Pharmacol | Herbal Medicine in the Treatment of Non-Alcoholic Fatty Liver Diseases-Efficacy, Action Mechanism, and Clinical Application. | 2020 | Details |
A07491 | 32475757 | Pancreatology | Liver and pancreas: 'Castor and Pollux' regarding the relationship between hepatic steatosis and pancreas exocrine insufficiency. | 2020 | Details |
A07500 | 32472367 | Curr Nutr Rep | Kefir in the Prevention and Treatment of Obesity and Metabolic Disorders. | 2020 | Details |
A07521 | 32460191 | Biomed Pharmacother | Sodium acetate-mediated inhibition of histone deacetylase alleviates hepatic lipid dysregulation and its accompanied injury in streptozotocin-nicotinamide-induced diabetic rats. | 2020 | Details |
A07543 | 32448832 | Intern Med | SGLT2 Inhibitor Treatment Outcome in Nonalcoholic Fatty Liver Disease Complicated with Diabetes Mellitus: The Long-term Effects on Clinical Features and Liver Histopathology. | 2020 | Details |
A07544 | 32448788 | BMJ Open Diabetes Res Care | Effects of a multifactorial ecosustainable isocaloric diet on liver fat in patients with type 2 diabetes: randomized clinical trial. | 2020 | Details |
A07558 | 32443971 | Hereditas | Relationship between circulating miR-132 and non-alcoholic fatty liver disease in a Chinese population. | 2020 | Details |
A07562 | 32443453 | Int J Environ Res Public Health | Utility of Liver Function Tests and Fatty Liver Index to Categorize Metabolic Phenotypes in a Mediterranean Population. | 2020 | Details |
A07572 | 32440112 | Int J Chron Obstruct Pulmon Dis | Sarcopenia Is an Independent Risk Factor for NAFLD in COPD: A Nationwide Survey (KNHANES 2008-2011). | 2020 | Details |
A07585 | 32435130 | Microbiol Insights | Presence of Hepatic Steatosis Does Not Increase the Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Over Long Follow-Up. | 2020 | Details |
A07595 | 32431115 | Diabetes Metab J | Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Position Statement of the Fatty Liver Research Group of the Korean Diabetes Association. | 2020 | Details |
A07602 | 32428560 | Biochim Biophys Acta Mol Basis Dis | Mitochondrial dysfunction in metabolic syndrome. | 2020 | Details |
A07609 | 32424494 | Adv Exp Med Biol | Non-alcoholic Fatty Liver Disease and Diabetes Mellitus. | 2021 | Details |
A07618 | 32418749 | Ann Hepatol | A Latin American survey on demographic aspects of hospitalized, decompensated cirrhotic patients and the resources for their management. | 2020 | Details |
A07629 | 32414752 | BMJ Open Gastroenterol | Spatial expression of glucagon-like peptide 1 receptor and caveolin-1 in hepatocytes with macrovesicular steatosis in non-alcoholic steatohepatitis. | 2020 | Details |
A07636 | 32413340 | Lancet Gastroenterol Hepatol | Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis. | 2020 | Details |
A07648 | 32409850 | Internist (Berl) | [New pharmacological treatment options for nonalcoholic fatty liver disease]. | 2020 | Details |